tradingkey.logo
tradingkey.logo
Search

CAMP4 Therapeutics Corp

CAMP
Add to Watchlist
3.800USD
-0.290-7.09%
Close 11-13 16:00(ET)
238.45MMarket Cap
LossP/E TTM

CAMP4 Therapeutics Corp (CAMP) Stock Price Target & Forecast

Analyst Rating

Based on 8 analysts giving stock ratings to CAMP4 Therapeutics Corp in the past month.

Strong Buy
4 Strong Buy
4 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
10.375USD+161.99%

CAMP Analyst Recommendation Trends

In the current month, CAMP has received 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. CAMP average Analyst price target in the last month is 10.375.

2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
Strong Buy
4
3
3
3
3
3
3
3
Buy
4
4
4
4
2
2
2
2
Hold
0
0
0
0
1
1
1
1
Strong Sell
0
0
0
0
0
0
0
0
Sell
0
0
0
0
0
0
0
0
Total
8
7
7
7
6
6
6
6

CAMP Analyst Rating for Peer Comparison

Updated: Nov 5, 2026
Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Ratings
Analysts
argenx SE
ARGX
10
14
3
0
0
27
Beigene Ltd
ONC
8
19
0
0
0
27
Ionis Pharmaceuticals Inc
IONS
6
16
4
0
0
26
Insmed Inc
INSM
6
18
1
0
0
25
Revolution Medicines Inc
RVMD
10
14
1
0
0
25
Ascendis Pharma A/S
ASND
9
13
1
0
0
23
CRISPR Therapeutics AG
CRSP
4
8
11
0
0
23
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
Tempus AI Inc
TEM
4
7
11
0
1
23
Biontech SE
BNTX
4
12
6
0
0
22

Financial Forecasting

Based on analysts' estimates, CAMP EPS is projected to reach -0.183 in FY2026Q4, following reported EPS of -0.367 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.

EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
FY2027Q1
Forecast
-0.21
-0.21
-0.19
-0.18
-0.16
Actual
-0.32
-0.58
-0.37
--
--
Surprise
-50.70%
-173.76%
-89.06%
--
--

FAQs

What is CAMP4 Therapeutics Corp's expected revenue for the next quarter?

CAMP4 Therapeutics Corp's expected revenue is 2.12M.

What is CAMP4 Therapeutics Corp's price target?

Analysts forecast that CAMP4 Therapeutics Corp's price target is USD 10.38, with the highest forecast at USD 15.00 and the lowest forecast at USD 6.00.

How have CAMP4 Therapeutics CorpCAMP's recent earnings per share performed?

The market expectation was USD -0.37, while CAMP4 Therapeutics CorpCAMP's earnings per share (EPS) for the previous quarter was USD -0.58. EPS for the next quarter is expected at USD -0.18.

What is the analyst rating for CAMP4 Therapeutics Corp?

Based on the ratings of CAMP4 Therapeutics Corp's stock from 8 analysts, most analysts support a STRONG BUY trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as STRONG BUY. Please note that this is not trading advice. You still need to conduct your own analysis.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.